Results 141 to 150 of about 933,936 (328)
Treating brain metastases in melanoma: What is the optimal CNS-directed and systemic management?
Thomas G. Wilson +3 more
openalex +1 more source
Advances in Bioprinting to Model Immune‐Mediated Skin Diseases
This review explores how 3D bioprinting drives innovation in developing in vitro skin models that mimic immune‐mediated diseases. It highlights current technologies, key applications in studying skin pathologies, and emerging challenges. The review points toward future opportunities for improving disease modeling and advancing therapeutic and cosmetic ...
Andrea Ulloa‐Fernández +4 more
wiley +1 more source
Advances in the development of tumor-infiltrating lymphocyte therapy for advanced melanoma [PDF]
Maximilian Julve, Andrew J.S. Furness
openalex +1 more source
This review explores how alternative invertebrate and small‐vertebrate models advance the evaluation of nanomaterials across medicine and environmental science. By bridging cellular and organismal levels, these models enable integrated assessment of toxicity, biodistribution, and therapeutic performance.
Marie Celine Lefevre +3 more
wiley +1 more source
Background Immunotherapy has significantly improved survival in patients with metastatic melanoma, achieving objective response rates of 45–60% and long-term survival. However, there is scope and a need to further improve outcomes.
Angela M. Hong +6 more
doaj +1 more source
Development of a prognostic nomogram for ocular melanoma: a SEER population-based study (2000–2021) [PDF]
Ming-Hui Zheng +3 more
openalex +1 more source
xx xx. ABSTRACT Stimuli‐responsive nanomaterials capable of spatiotemporal control over drug release are of nanocomposite patch (“e‐Medi‐Patch”) engineered from biodegradable polycaprolactone (PCL), graphene nanoplatelets, and a redox‐active therapeutic, niclosamide. The hierarchical composite integrates π‐π interactions between aromatic drug molecules
Santosh K. Misra +7 more
wiley +1 more source
Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA [PDF]
Mengke Zhao +13 more
openalex +1 more source
Bioorthogonal chemistry was applied to intracellularly photoactivate Doxorubicin (Dox) using gold nanostars (AuNSt) and near‐infrared (NIR) light. Two prodrugs were used: one photoactivatable, masked with 2‐nitrobenzyl carbamate (proDox1) and another photolabile, masked with 2‐nitrobenzyl diol (proDox2), which was attached to the AuNSt surface.
Juan José Esteve‐Moreno +15 more
wiley +1 more source

